All In Biotech

Drug Trial Radar · NCT04835038

Effects of BRS and LRS on Postoperative Acute Kidney Injury

Effects of Sodium Bicarbonate Ringer's Injection and Sodium Lactated Ringer's Injection on Postoperative Acute Kidney Injury in Patients Undergoing Major Abdominal Surgery: a Randomized, Controlled, Open-label Clinical Study

Last checked: Nov 20, 2026Latest source record: Apr 12, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 3,400 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

3,400

Planned (sponsor's estimate)

Start

Jun 1, 2021

Primary completion

Jun 2023

Study completion Aug 2023

Sponsor

Lead sponsor
Tongji HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 8, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 20 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

1. Title: Effects of Sodium Bicarbonate Ringer's Injection and Sodium Lactated Ringer's Injection on postoperative acute kidney injury in patients undergoing major abdominal surgery: a randomized, controlled, open-label clinical study 2. Objective: To evaluate the effect of BRS and LRS infusion on acute renal injury in patients undergoing major abdominal surgery 3. Primary outcome: Incidence of AKI at 28 days postoperative (defined as acute kidney injury, according to Kidgo 2012 definition and classification). 4. Study Design: Randomized, controlled, open-label clinical study.

Conditions

  • Acute Kidney Injury

Interventions

  • Sodium Bicarbonate Ringer's InjectionDrug

    Intraoperative fluid therapy performed with BRS (Sodium Bicarbonate Ringer's Injection)

  • Sodium Lactated Ringer's InjectionDrug

    Intraoperative fluid therapy performed with LRS (Sodium Lactated Ringer's Injection)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Postoperative acute renal injuryTime frame: 28 days after surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tongji hospital

    Wuhan, Hubei, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.